1. Home
  2. RUSHB vs RYTM Comparison

RUSHB vs RYTM Comparison

Compare RUSHB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Class B

RUSHB

Rush Enterprises Inc. Class B

SELL

Current Price

$57.52

Market Cap

6.5B

ML Signal

SELL

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$86.27

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUSHB
RYTM
Founded
1965
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.3B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
RUSHB
RYTM
Price
$57.52
$86.27
Analyst Decision
Strong Buy
Analyst Count
0
19
Target Price
N/A
★ $143.94
AVG Volume (30 Days)
185.3K
★ 705.8K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
★ 0.97%
N/A
EPS Growth
N/A
★ 28.34
EPS
★ 1.68
N/A
Revenue
★ $7,434,195,000.00
N/A
Revenue This Year
$4.20
$66.07
Revenue Next Year
$10.82
$79.32
P/E Ratio
$34.49
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$47.71
$74.50
52 Week High
$81.52
$122.20

Technical Indicators

Market Signals
Indicator
RUSHB
RYTM
Relative Strength Index (RSI) 49.55 28.22
Support Level $56.80 $82.43
Resistance Level $67.24 $92.51
Average True Range (ATR) 1.70 3.29
MACD 0.80 -0.21
Stochastic Oscillator 75.13 10.27

Price Performance

Historical Comparison
RUSHB
RYTM

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: